Skip to main content
OpenTrials
Completed

NCT Number: NCT07027696

Sexual Health of Women With Genital Mutilation Seen at the Saint-Denis Women's Center

This study looks at the sexual health of women who have experienced female genital mutilation (FGM) and who are receiving care at the Women's Center at Saint-Denis Hospital. It aims to better understand their sexual experiences, including the impact of past violence and trauma, and to explore how multidisciplinary care (such as psychological and sexological support) can help. The study also looks at what women expect from their care and how they feel about surgical or other types of support.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women with female genital mutilation (FGM), or considered to be excised, consulting at the Maison des Femmes (Women's House) at Saint-Denis Hospital.
  • Women enrolled in the multidisciplinary care pathway for FGM.

Exclusion criteria

  • Women under the age of 15.

Treatment and study plan

Primary outcomes

  1. Assessment of the sexual function profile of women with female genital mutilation (FGM) during consensual sexual activity, using a structured clinical sexological evaluation that accounts for histories of violence.

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Saint-Denis

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jun 18, 2025
Registry last updated
Jun 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.